European Journal of Medicinal Chemistry p. 480 - 501 (2019)
Update date:2022-08-15
Topics:
Pan, Ting
Ding, Yanchao
Wu, Liyang
Liang, Liting
He, Xin
Li, Qianwen
Bai, Chuan
Zhang, Hui
The capsid assembly is an essential step for Hepatitis B Virus (HBV) life cycle and is an important target for anti-HBV drug development. In this report, we identified a hit compound with aminothiazole structure by the high throughput screening (HTS) which inhibited the interaction of HBV capsid protein within the cells. The structure hopping and SAR studies of the hit compound afforded compound 79 with potent anti-HBV replication activity and good basic drug-like properties. The working mechanism studies showed that compound 79 could bind to the similar binding site of known HBV capsid inhibitor with heteroaryldihydropyrimidine (HAP) scaffold, through similar hydrophobic interactions but with a different hydrogen bond. This compound exerted potent inhibitory effect upon HBV production, either in cell culture or in mice with no obvious acute toxicity. We propose that further development of this compound could lead to novel potent anti-HBV inhibitors that target HBV capsid assembly.
View MoreContact:+86-10-62651721
Address:29 Yongxing Road, Daxing District,Beijing China
Nanjing lanbai chemical Co.,Ltd.
Contact:+86-25-85499326
Address:Room 908, 9F Taiyue Building,No.285 Heyan Road
website:http://www.hanwayschem.com
Contact:+86-18502787239(whatsapp)
Address:18-1-802, Green Garden, Jianghan District, Wuhan 430023, China
SHENZHEN PENGCHENG REDSTAR INDUSTRY CO.,LTD
Contact:+86-755-82412922
Address:Room 8066, East Block, Square City, Jiabin Road, Luohu District
Antaeus Bio-technology Co., LTD
Contact:021-31252569
Address:shanghai pudong
Doi:10.1002/hlca.19640470809
(1964)Doi:10.1039/C6CE02292H
(2017)Doi:10.1021/jo00816a011
(1971)Doi:10.1021/ol7030153
(2008)Doi:10.1039/j39710000343
(1971)Doi:10.1016/0022-328X(85)87383-6
(1985)